mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.002 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.002 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |